Screener
Olema Pharmaceuticals, Inc. OLMA Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Accounts payable | (5,681) | (4,309) |
| Other current liabilities | 1,304 | (11,248) |
| Operating lease liabilities | (313) | (309) |
| Net cash used in operating activities | (45,987) | (43,979) |
| Cash flows from investing activities: | ||
| Maturities of marketable securities | 74,470 | 97,772 |
| Purchases of marketable securities | (69,941) | (142,855) |
| Net cash provided by (used in) investing activities | 4,529 | (45,083) |
Item 1. Financial Statements.
FAQ
- What is Olema Pharmaceuticals, Inc.'s operating cash flow?
- Olema Pharmaceuticals, Inc. (OLMA) reported operating cash flow of -$45.99M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Olema Pharmaceuticals, Inc.'s operating cash flow decreased by 4.6% year-over-year, from -$43.98M to -$45.99M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s operating cash flow has grown at a 30.4% compound annual growth rate (CAGR), from -$50.69M to -$146.72M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Olema Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude